# Optimizing Early Cesarean Scar Healing

> **NCT07547462** · NA · COMPLETED · sponsor: **Hamad Medical Corporation** · enrollment: 117 (actual)

## Conditions studied

- Cesarean Section Scar
- Wound Healing

## Interventions

- **DRUG:** Beta-Sitosterol Ointment
- **DRUG:** Hydrophilic Methacrylate Gel

## Key facts

- **NCT ID:** NCT07547462
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-15
- **Primary completion:** 2024-10-08
- **Final completion:** 2024-11-01
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07547462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07547462, "Optimizing Early Cesarean Scar Healing". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07547462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*